---
title: "BofAS Raises WUXI APPTEC  TP to HKD204.3, Lifts Earnings and Revenue Forecasts; Interim Results Beat Expectations"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294908691.md"
description: "BofAS raised WUXI APPTEC's target price to HKD204.3 and upgraded earnings and revenue forecasts by 37.5% and 12.9%, respectively, citing strong H1 performance that beat expectations. The broker maintained a 'Buy' rating, highlighting robust backlog growth of 25.2% YoY, improved margins, and easing concerns regarding the US Biosecure Act due to strong project growth."
datetime: "2026-08-05T04:16:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294908691.md)
  - [en](https://longbridge.com/en/news/294908691.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294908691.md)
generator: "portal-rs"
---

# BofAS Raises WUXI APPTEC  TP to HKD204.3, Lifts Earnings and Revenue Forecasts; Interim Results Beat Expectations

BofAS issued a research report saying that WUXI APPTEC (02359.HK) +2.200 (+1.215%) Short selling $1.17B; Ratio 33.055% recorded strong revenue and profit growth in the first half of the year, exceeding the broker's full-year expectations. All business segments achieved growth. Backlog orders for continuing operations reached RMB66.43 billion, up 25.2% YoY, providing good visibility for revenue growth. The broker reiterated its "Buy" rating.

Considering stronger commercialization of pipeline products, better-than-expected sales growth and margin improvement, BofAS raised its forecasts for WUXI APPTEC's revenue and adjusted earnings for this year by 12.9% and 37.5%, respectively. The H-share TP was raised from HKD171.7 to HKD204.3. The broker believed the interim results reflected solid demand for small molecule and peptide businesses, accelerating commercialization conversion and improving operating leverage. In addition, strong growth in US projects also eased market concerns over the Biosecure Act.(gc/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-08-04 16:25.)

### Related Stocks

- [02359.HK](https://longbridge.com/en/quote/02359.HK.md)
- [603259.CN](https://longbridge.com/en/quote/603259.CN.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [20:00 ETWuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion](https://longbridge.com/en/news/297441220.md)
- [WuXi AppTec files HKEX next-day return, lifts share capital by 13,631,632 H shares on bond conversion at HKD 153 each](https://longbridge.com/en/news/297310563.md)
- [WUXI APPTEC  Biology Business DEL Platform Experiences Cybersecurity Incident](https://longbridge.com/en/news/296820305.md)
- [WUXI APPTEC  to Early Redeem Convertible Bonds Due 2027 with Principal of RMB4.973 Billion](https://longbridge.com/en/news/297424830.md)
- [WuXi AppTec says cyberattack hits DEL platform data, operations unaffected](https://longbridge.com/en/news/296804345.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**